Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT

NuklearMedizin

Volumn 46, Issue 1, 2007, Pages 9-14

  Pauls, S ^a   Buck, A K ^a   Hohl, K ^a   Halter, G ^a   Hetzel, M ^a   Blumstein, N M ^a   Mottaghy, Felix M ^a,b   Glatting, G ^a   Kruger S ^a   Sunder Plassmann, L ^a   Moller P ^a   Hombach, V ^a   Brambs, H J ^a   Reske, S N ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

MDCT; NSCLC; PET; PET CT; T staging

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; IOPROMIDE;

ACCURACY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; PREDICTION;

EID: 33847746339     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616618     Document Type: Article

References (34)

1. Antoch G, Stattaus J, Nemat AT et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 299: 526-33.
2. Belvedere O, Grossi F. Lung cancer highlights from ASCO 2005. Oncologist 2006; 11: 39-50.
3. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002; 122: 1037-57.
4. Cerfolio RJ, Ojha B, Bryant AS et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004; 78: 1017-23.
5. Chooi WK, Matthews S, Bull MJ et al. Multislice computed tomography in staging lung cancer: the role of multiplanar image reconstruction. J Comput Assist Tomogr 2005; 29: 357-60.
6. Czernin J, Auerbach MA. Clinical PET/CT imaging. Nucl Med 2005; 44: S18-23.
7. Gilman MD, Equino SL. State-of-the-art FDG PET imaging of lung cancer. Semin Roentgenol 2005; 40: 143-53.
8. Goerres GW, Kamel E, Seifert B et al. Accuracy of image coregistration of pulmonary lesions in patients with non-msall cell lung cancer using an integrated PET/CT system. J Nucl Med 2002; 43: 1469-75.
9. th ed. TNM Classification of Malignant Tumors. New York, Berlin, Heidelberg: Springer 2002; 191-203.
10. 18F fluorodeoxyglucose imaging in differentiation of benign from malignant lung / mediastinal lesions. Chest 1998; 114: 1105-11.
11. Halpern BS, Schiepers C, Weber WA et al. Presurgical staging of non-small cell lung cancer - positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005; 128: 2289-97.
12. 18F- FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 2001; 42: 1596-604.
13. Hübner KF, Buonocore E, Gould HR et al. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. Clin Nucl Med 1996; 21: 941-9.
14. 18F fluorodeoxyglucose positron emission tomography in patients with non-small cell lung cancer: a prospective study. J Clin Oncol 2001; 19: 111-8.
15. 18F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003; 44: 1911-7.
16. Kuehl H, Antoch G. How much CT do we need for PET/CT. Nucl Med 2005; 44: S24-31.
17. Lardinois D, Weder W, Hany TF et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-7.
18. Marom EM, McAdams HP, Erasmus JJ et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212: 803-9.
19. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-23.
20. Naruke T, Goya T, Tsuchiya R et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. Thorac Cardiovasc Surg 1988; 96: 440-7.
21. Pastorino U, Bellomi M, Landoni C et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362: 593-7.
22. Pfister DG, Johnson DH, Azzoli DG et al. American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003. J Clin Oncol 2004; 22: 330-52.
23. Pieterman RM, van Putten JWG, Meuzelaar JJ et al. Preoperative staging of non-small-cell lung cancer with 18-fluorodeoxyglucose positron-emission tomography. N Engl J Med 2000; 343: 254-61.
24. 18F-fluorodeoxyglucose. Ann Thorac Surg 1994; 58: 698-703.
25. Shah SK, McNitt-Gray MF, Rogers SR et al. Computer aided characterization of the solitary pulmonary nodule using volumetric and contrast enhancement features. Acad Radiol 2005; 12: 1310-9.
26. Shim SS, Lee KS, Kim B-T et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236: 1011-9.
27. Silvestri GA, Tanoue LT, Margolis ML et al. The non-invasive staging of non-small cell lung cancer: the guidelines. Chest 2003; 123: 147S-56S.
28. Strobel K, Thuerl M, Hany TF. How much intravenous contrast is needed in FDG-PET/CT? Nucl Med 2005; 44: S32-7.
29. Swensen SJ, Brown LR, Colby TV et al. Lung nodule enhancement at CT: prospective findings. Radiology 1996; 201: 447-55.
30. Travis WD, Garg K, Franklin WA et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005; 23: 3279-87.
31. Vansteenkiste J, Fischer BM, Dooms C et al. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systemic review. Lancet Oncol 2004; 5: 531-40.
32. Verschakelen JA, De Wever W, Bogaert J. Role of computed tomography in lung cancer staging. Curr Opin Pulm Med 2004; 10: 248-55.
33. Watanabe Y. TNM classification for lung cancer. Ann Thorac Cardiovasc Surg 2003; 9: 343-50.
34. Webb WR. Lung cancer and bronchopulmonary neoplasm. In: Webb WR, Higgins CB (eds). Thoracic imaging. Lippincott Williams & Wilkins 2005; 75-7.